Efficacy of Oral Appliance for Upper Airway Resistance Syndrome

Sponsor
Associação Fundo de Incentivo à Pesquisa (Other)
Overall Status
Unknown status
CT.gov ID
NCT02636621
Collaborator
(none)
60
1
2
48
1.3

Study Details

Study Description

Brief Summary

Introduction: The Upper Airway Resistance Syndrome (UARS) is a sleep disorder characterized by airway resistance to breathing during sleep that leads to arousals and daytime sleepiness. There are few studies about UARS treatment and there is not any gold standard treatment for it yet.

Objective: Primary: To evaluate the efficacy of oral appliance on improving fatigue in patients with UARS. Secondary: Evaluate the effects of treatment with oral appliance (OA) in patients with UARS on sleepiness, mood, cognition, quality of life, metabolism and autonomic nervous system.

Methods: Subjects with UARS (Apnea/Hypopnea Index - AHI - ≤ 5 events per hour of sleep and Respiratory Disturbance Index - RDI - > 5 events per hour or more than 30% of total sleep time with inspiratory flow limitation and with excessive daytime somnolence and/or fatigue) of both genders, with body mass index (BMI) lower than 30Kg/m2 and between 25 to 50 years of age will be included. Subjects will be randomly distributed in OA group and placebo (without treatment). At baseline evaluation, 6 months and 1 year after subjects will be submitted to sleep questionnaires, physical exam, otolaryngological evaluation, baseline polysomnography, Epworth sleepiness scale, Multiple Sleep Latency Test, fatigue scale, neurocognitive testing, autonomic nervous system analysis (heart rate variability) and metabolic evaluation. Mean and standard deviation will be used for descriptive statistical analysis if normal distribution, and median and percentiles (25%, 75%) for variables not normally distributed. To compare treatment groups T test (parametric) and Mann Whitney (non parametric) will be used. For adjusted analysis, linear regression analysis will be used.

Condition or Disease Intervention/Treatment Phase
  • Device: Brazilian Dental Appliance
  • Other: Placebo
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
60 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Single (Participant)
Primary Purpose:
Treatment
Official Title:
Efficacy of Oral Appliance for Upper Airway Resistance Syndrome: Randomized, Parallel, Placebo, Controlled Study
Study Start Date :
Oct 1, 2013
Anticipated Primary Completion Date :
Oct 1, 2017
Anticipated Study Completion Date :
Oct 1, 2017

Arms and Interventions

Arm Intervention/Treatment
Active Comparator: Brazilian Dental Appliance

The device increases the volume of the airway by mandibular traction.

Device: Brazilian Dental Appliance
Brazilian Dental Appliance is an oral appliance worn only during sleep that supports the jaw in a forward position to help maintain an open upper airway.
Other Names:
  • Mandibular advancement device
  • Placebo Comparator: Placebo

    Oral device that does not change the volume of the airway

    Other: Placebo
    The placebo consists in a protective dental plate worn only during sleep that do not interfere in the size of the upper airway.
    Other Names:
  • Protective dental plate
  • Outcome Measures

    Primary Outcome Measures

    1. Fatigue [From the baseline evaluation to one year after the treatment with oral appliance]

      Modified fatigue impact scale for Portuguese (MFIS- BR)

    Secondary Outcome Measures

    1. Subjective excessive daytime sleepiness [From the baseline evaluation to one year after the treatment with oral appliance]

      Epworth sleepiness scale

    2. Objective excessive daytime sleepiness [From the baseline evaluation to one year after the treatment with oral appliance]

      Multiple Sleep Latency Test

    3. Mood - Anxiety [From the baseline evaluation to one year after the treatment with oral appliance]

      Beck inventories (BAI)

    4. Mood - Depression [From the baseline evaluation to one year after the treatment with oral appliance]

      Beck inventories (BDI)

    5. Sustained attention [From the baseline evaluation to one year after the treatment with oral appliance]

      Psychomotor Vigilance Test (PVT)

    6. Cognition - Memory [From the baseline evaluation to one year after the treatment with oral appliance]

      Digit Symbol Substitution Test (DSST)

    7. Cognition - Learning strategies [From the baseline evaluation to one year after the treatment with oral appliance]

      Rey Auditory-Verbal Learning Test (RAVLT)

    8. Cognition - Immediate and late memories [From the baseline evaluation to one year after the treatment with oral appliance]

      Wechsler Memory Scale (WMS)

    9. Cognition - Processing speed ability [From the baseline evaluation to one year after the treatment with oral appliance]

      Stroop Color Test

    10. Cognition - Visual attention [From the baseline evaluation to one year after the treatment with oral appliance]

      Trail Making Test - TMT

    11. Quality of sleep [From the baseline evaluation to one year after the treatment with oral appliance]

      Pittsburgh Sleep Quality Index (PSQI)

    12. Quality of life [From the baseline evaluation to one year after the treatment with oral appliance]

      Functional Outcomes of Sleep Questionnaire (FOSQ)

    13. Stress [From the baseline evaluation to one year after the treatment with oral appliance]

      Teste de Lipp

    14. Metabolism [From the baseline evaluation to one year after the treatment with oral appliance]

      Blood analysis of metabolism

    15. Autonomic nervous system analysis [From the baseline evaluation to one year after the treatment with oral appliance]

      Heart rate variability

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    25 Years to 50 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:
    • Both genders

    • Body mass index (BMI) ≤ 30Kg/m2

    • Age from 25 to 50 years

    • Clinical and polysomnographic diagnosis of Upper Airway Resistance Syndrome: Apnea/Hypopnea Index (AIH) ≤ 5 events/hour and Respiratory Disturbance Index (RDI) > 5 events/hour or > 30% of total sleep time with inspiratory flow limitation with excessive daytime somnolence or fatigue

    Exclusion Criteria:
    • Unsatisfactory dental condition or severe temporomandibular disfunction;

    • Nasal obstruction;

    • Alcohol abuse and excessive consumption of psychotropic drugs;

    • Clinical, neurological or psychiatric diseases not treated

    • Less than 6 hours of sleep

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Associação Fundo de Incentivo à Pesquisa (AFIP) São Paulo Brazil 04024-002

    Sponsors and Collaborators

    • Associação Fundo de Incentivo à Pesquisa

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Sonia Maria Guimaraes Pereira Togeiro Moura, Prof. Dra. Sonia Guimaraes Togeiro Moura, Associação Fundo de Incentivo à Pesquisa
    ClinicalTrials.gov Identifier:
    NCT02636621
    Other Study ID Numbers:
    • SR94036
    First Posted:
    Dec 22, 2015
    Last Update Posted:
    Jul 15, 2016
    Last Verified:
    Jul 1, 2016
    Keywords provided by Sonia Maria Guimaraes Pereira Togeiro Moura, Prof. Dra. Sonia Guimaraes Togeiro Moura, Associação Fundo de Incentivo à Pesquisa
    Additional relevant MeSH terms:

    Study Results

    No Results Posted as of Jul 15, 2016